Silencing of LINC00467 inhibits cell proliferation in testicular germ cell tumors cells.
Journal
Biomolecules & biomedicine
ISSN: 2831-090X
Titre abrégé: Biomol Biomed
Pays: Bosnia and Herzegovina
ID NLM: 9918522188506676
Informations de publication
Date de publication:
04 Sep 2023
04 Sep 2023
Historique:
received:
03
03
2023
accepted:
12
04
2023
medline:
7
9
2023
pubmed:
20
4
2023
entrez:
20
04
2023
Statut:
epublish
Résumé
A significant decrease in LINC00467 expression in testicular germ cell tumors (TGCTs) was found in our previous study in comparison to adjacent tissue. Interestingly, the expression of LINC00467 correlated with the pathological grade of the tumor in TGCT patients. The higher the expression of LINC00467 was, the worse the prognosis of the patients with TGCT was. Despite these findings, the exact role of LINC00467 in the development of TGCTs requires further investigation. LINC00467 expression was downregulated in the NCCIT and TCam-2 cell lines via small interfering RNA (siRNA) silencing. The levels of gene expression were validated using quantitative real-time polymerase chain reaction (qRT-PCR) analyses. Cell proliferation was evaluated by the MTT and Cell Counting Kit-8 (CCK8) assays, whereas flow cytometry was used to assess the effects on the cell cycle. Western blotting analysis was used to detect expression levels of protein. Additionally, RNA-sequencing and bioinformatics methods were used to investigate the mechanism of action of LINC00467 in TGCTs. The suppression of LINC00467 expression resulted in decreased cell proliferation and induced S-phase arrest. Furthermore, the suppression of LINC00467 downregulated proliferating cell nuclear antigen (PCNA), a protein related to cell cycle regulation, while it upregulated p21 expression. In other studies involving dihydrotestosterone (DHT) stimulation, it was observed that DHT could upregulate LINC00467 expression. In addition, silencing of the LINC00467 reversed the effect of testosterone on cell proliferation. The Gene Set Enrichment Analysis (GSEA) revealed that LINC00467 regulated the p53 pathway by modulating the expression of CCNG1. Our study found that LINC00467 regulates cell proliferation by inducing S-phase arrest through the cell cycle-related proteins PCNA and p21. These findings contribute to our understanding of non-coding RNAs mechanisms involved in the development of TGCTs.
Identifiants
pubmed: 37078359
doi: 10.17305/bb.2023.8969
pmc: PMC10494854
doi:
Substances chimiques
Proliferating Cell Nuclear Antigen
0
RNA, Small Interfering
0
CCNG1 protein, human
0
Cyclin G1
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
802-814Références
Cancer Immunol Immunother. 2021 Mar;70(3):569-588
pubmed: 32902664
J Biol Chem. 2001 Dec 28;276(52):49258-66
pubmed: 11595739
Oncol Lett. 2020 Nov;20(5):124
pubmed: 32934693
Cell Death Discov. 2021 Aug 6;7(1):206
pubmed: 34362879
Hum Reprod. 2018 Jun 1;33(6):1087-1098
pubmed: 29635626
Cancer Lett. 2014 Apr 28;346(1):24-33
pubmed: 24368189
Am J Physiol Cell Physiol. 2013 Aug 1;305(3):C355-9
pubmed: 23720021
Nucleic Acids Res. 2014 Jul;42(13):8433-48
pubmed: 24939902
Front Endocrinol (Lausanne). 2021 Sep 21;12:743155
pubmed: 34621245
J Pathol. 2007 Nov;213(3):319-28
pubmed: 17893849
Cancer Cell. 2016 Apr 11;29(4):452-463
pubmed: 27070700
Cancer Cell. 2015 Apr 13;27(4):450-61
pubmed: 25858804
Clin Oncol (R Coll Radiol). 2019 Sep;31(9):653-658
pubmed: 31056287
Nat Rev Cancer. 2005 Mar;5(3):210-22
pubmed: 15738984
Cancers (Basel). 2021 Apr 16;13(8):
pubmed: 33923536
J Clin Oncol. 2012 Oct 20;30(30):3752-63
pubmed: 23008318
Andrology. 2019 Jul;7(4):527-535
pubmed: 31310060
Clin Epigenetics. 2019 Dec 3;11(1):179
pubmed: 31796056
N Engl J Med. 2014 Nov 20;371(21):2005-16
pubmed: 25409373
Lancet. 2016 Apr 23;387(10029):1762-74
pubmed: 26651223
Oncogene. 2020 Sep;39(38):6071-6084
pubmed: 32796958
Eur J Cancer. 2015 Oct;51(15):2206-2216
pubmed: 26421823
Nat Rev Urol. 2018 Nov;15(11):665-666
pubmed: 30250305
Physiol Rev. 2016 Oct;96(4):1297-325
pubmed: 27535639
Am J Clin Pathol. 2011 Jan;135(1):119-25
pubmed: 21173133
J Cell Mol Med. 2019 Nov;23(11):7773-7784
pubmed: 31496041
Eur Urol. 2014 Jun;65(6):1095-106
pubmed: 24268506
Cancer Res. 2010 Apr 1;70(7):2911-23
pubmed: 20332240
Mol Cancer. 2010 Nov 08;9:290
pubmed: 21059207
PLoS Comput Biol. 2021 Apr 16;17(4):e1008918
pubmed: 33861746
Sci Rep. 2018 Feb 6;8(1):2462
pubmed: 29410498
Int J Cancer. 2011 Jun 1;128(11):2572-80
pubmed: 20715113
Andrologia. 2021 Apr;53(3):e13986
pubmed: 33544925
Sci Rep. 2015 Nov 02;5:15972
pubmed: 26522444
Oxid Med Cell Longev. 2021 Dec 15;2021:4586319
pubmed: 34956437
J Thorac Oncol. 2011 Dec;6(12):1984-92
pubmed: 22088988
Oncol Lett. 2017 Jul;14(1):981-986
pubmed: 28693262
Open Biol. 2019 Sep 27;9(9):190074
pubmed: 31480990
Nat Rev Urol. 2021 Apr;18(4):227-245
pubmed: 33686290
PLoS One. 2014 Feb 19;9(2):e88112
pubmed: 24586304